Hadi Hassannia Selected Research

human ROR1 protein

2/2018

Detecting Receptor Tyrosine Kinase ROR1 Using a Developed Anti-ROR1 Polyclonal Antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hadi Hassannia Research Topics

Disease

22	Neoplasms (Cancer) 08/2022 - 06/2016
9	Breast Neoplasms (Breast Cancer) 08/2022 - 06/2016
6	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Toxoplasmosis 01/2021 - 04/2020
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 11/2020
1	COVID-19 04/2022
1	Multiple Sclerosis 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Keratitis 11/2020
1	Seizures (Absence Seizure) 04/2020
1	Epilepsy (Aura) 04/2020
1	Parasitic Diseases (Parasitic Disease) 04/2020
1	Cysts 04/2020
1	Hypoxia (Hypoxemia) 10/2018
1	Adenocarcinoma 02/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Allergic Rhinitis 12/2011

Drug/Important Bio-Agent (IBA)

16	Small Interfering RNA (siRNA)IBA 08/2022 - 06/2016
10	chitosan lactateIBA 12/2021 - 06/2016
9	VaccinesIBA 08/2022 - 01/2017
7	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 06/2016
5	CytokinesIBA 02/2022 - 01/2017
4	InterleukinsIBA 02/2022 - 01/2017
3	ChitosanIBA 02/2022 - 12/2020
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2022 - 06/2021
3	Peptides (Polypeptides)IBA 09/2021 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2018
2	Immune Checkpoint ProteinsIBA 01/2022 - 10/2020
2	ferric oxide (iron oxide)IBA 12/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 09/2021 - 10/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021 - 06/2021
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2020 - 07/2019
2	guluronic acidIBA 04/2020 - 01/2018
2	AntigensIBA 04/2020 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 01/2018
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018 - 01/2017
1	CateninsIBA 02/2022
1	Interleukin-15 (Interleukin 15)IBA 02/2022
1	beta CateninIBA 02/2022
1	carboxymethyl dextranIBA 02/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	A-Form DNA (A-DNA)IBA 01/2021
1	aluminum sulfate (alum)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	DNA VaccinesIBA 01/2021
1	AlginatesIBA 12/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2020
1	CTLA-4 AntigenIBA 10/2020
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2020
1	Pentylenetetrazole (Metrazol)IBA 04/2020
1	Recombinant ProteinsIBA 04/2020
1	AntioxidantsIBA 04/2020
1	Surface Antigens (Surface Antigen)IBA 04/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2018
1	cadherin 5IBA 10/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2018
1	human ROR1 proteinIBA 02/2018
1	ParaffinIBA 02/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2018
1	EpitopesIBA 11/2017
1	human ERBB2 proteinIBA 11/2017
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 11/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	InterferonsIBA 01/2017
1	mannuronic acidIBA 01/2017
1	ectoATPaseIBA 06/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2011
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2011

Therapy/Procedure

11	Therapeutics 08/2022 - 06/2016
8	Immunotherapy 02/2022 - 01/2017
2	Ligation 01/2022 - 10/2020
2	Drug Therapy (Chemotherapy) 09/2021 - 06/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Contact Lenses 11/2020
1	Injections 04/2020
1	Transplantation 01/2018
1	Intravenous Administration 01/2017